...
首页> 外文期刊>Arteriosclerosis, thrombosis, and vascular biology >Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension
【24h】

Sildenafil potentiates bone morphogenetic protein signaling in pulmonary arterial smooth muscle cells and in experimental pulmonary hypertension

机译:西地那非可增强肺动脉平滑肌细胞和实验性肺动脉高压中的骨形态发生蛋白信号传导

获取原文
获取原文并翻译 | 示例
           

摘要

Objective-Mutations in the bone morphogenetic protein type II receptor (BMPR-II) are responsible for the majority of cases of heritable pulmonary arterial hypertension (PAH), and BMPR-II deficiency contributes to idiopathic and experimental forms of PAH. Sildenafil, a potent type-5 nucleotide-dependent phosphodiesterase inhibitor, is an established treatment for PAH, but whether sildenafil affects bone morphogenetic protein (BMP) signaling in the pulmonary circulation remains unknown. Methods and Results-Studies were undertaken in human pulmonary arterial smooth muscle cells (PASMCs) and in vivo in the monocrotaline rat model of PAH. In PASMCs, sildenafil enhanced BMP4-induced phosphorylation of Smad1/5, Smad nuclear localization, and Inhibitor of DNA binding protein 1 gene and protein expression. This effect was mimicked by 8-bromo-cyclic GMP. Pharmacological inhibition or small interfering RNA knockdown of cyclic GMP-dependent protein kinase I inhibited the effect of sildenafil on BMP signaling. In functional studies, we observed that sildenafil potentiated the antiproliferative effects of BMP4 on PASMC proliferation. Furthermore, sildenafil restored the antiproliferative response to BMP4 in PASMCs harboring mutations in BMPR-II. In the monocrotaline rat model of PAH, which is characterized by BMPR-II deficiency, sildenafil prevented the development of pulmonary hypertension and vascular remodeling, and partly restored Smad1/5 phosphorylation and Inhibitor of DNA binding protein 1 gene expression in vivo in monocrotaline exposed rat lungs. Conclusion-Sildenafil enhances canonical BMP signaling via cyclic GMP and cyclic GMP-dependent protein kinase I in vitro and in vivo, and partly restores deficient BMP signaling in BMPR-II mutant PASMCs. Our findings demonstrate a novel mechanism of action of sildenafil in the treatment of PAH and suggest that targeting BMP signaling may be beneficial in this disease.
机译:在大多数遗传性肺动脉高压(PAH)病例中,II型骨形态发生蛋白受体(BMPR-II)的客观突变是造成原因的,而BMPR-II缺乏则是PAH的特发性和实验性形式。西地那非是一种有效的5型核苷酸依赖性磷酸二酯酶抑制剂,是一种公认​​的PAH治疗药物,但西地那非是否会影响肺循环中的骨形态发生蛋白(BMP)信号传递尚不清楚。方法和结果-在人肺动脉平滑肌细胞(PASMC)中以及在PAH的单crocroline大鼠模型中进行了体内研究。在PASMC中,昔多芬可增强BMP4诱导的Smad1 / 5磷酸化,Smad核定位以及DNA结合蛋白1基因和蛋白表达的抑制剂。该效果被8-溴环GMP模仿。药理学抑制或环状GMP依赖性蛋白激酶I的小干扰RNA敲低抑制了西地那非对BMP信号传导的影响。在功能研究中,我们观察到西地那非增强了BMP4对PASMC增殖的抗增殖作用。此外,西地那非在具有BMPR-II突变的PASMC中恢复了对BMP4的抗增殖反应。在以BMPR-II缺乏为特征的PAH的单crocrotaline大鼠模型中,sildenafil预防了肺动脉高压的发展和血管重塑,并部分恢复了Scro1 / 5磷酸化和DNA结合蛋白1基因抑制剂在体内的作用。肺。结论:Sildenafil可在体内外通过循环GMP和依赖于循环GMP的蛋白激酶I增强经典BMP信号传导,并部分恢复BMPR-II突变型PASMC中的BMP信号传导不足。我们的发现证明了西地那非治疗PAH的新作用机制,并提示靶向BMP信号传导可能在这种疾病中有益。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号